DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $431,000 | +29.8% | 1,940 | +26.0% | 0.09% | +60.3% |
Q3 2020 | $332,000 | +7.8% | 1,540 | -11.5% | 0.06% | -13.4% |
Q2 2020 | $308,000 | +14.5% | 1,740 | -10.3% | 0.07% | -6.9% |
Q1 2020 | $269,000 | -8.8% | 1,940 | +1.0% | 0.07% | +16.1% |
Q4 2019 | $295,000 | +1.0% | 1,920 | -5.0% | 0.06% | -10.1% |
Q3 2019 | $292,000 | +1.0% | 2,020 | -0.2% | 0.07% | +1.5% |
Q2 2019 | $289,000 | +19.9% | 2,025 | +11.0% | 0.07% | +13.3% |
Q1 2019 | $241,000 | +16.4% | 1,825 | -9.2% | 0.06% | +3.4% |
Q4 2018 | $207,000 | +4.5% | 2,010 | +10.1% | 0.06% | +26.1% |
Q3 2018 | $198,000 | +10.0% | 1,825 | 0.0% | 0.05% | 0.0% |
Q2 2018 | $180,000 | -7.2% | 1,825 | -8.0% | 0.05% | -8.0% |
Q1 2018 | $194,000 | +5.4% | 1,984 | 0.0% | 0.05% | -12.3% |
Q4 2017 | $184,000 | +8.2% | 1,984 | 0.0% | 0.06% | +1.8% |
Q3 2017 | $170,000 | +1.8% | 1,984 | 0.0% | 0.06% | -1.8% |
Q2 2017 | $167,000 | -1.8% | 1,984 | 0.0% | 0.06% | 0.0% |
Q1 2017 | $170,000 | +6.2% | 1,984 | -3.3% | 0.06% | +1.8% |
Q4 2016 | $160,000 | -24.9% | 2,051 | -24.3% | 0.06% | -26.3% |
Q3 2016 | $213,000 | -22.3% | 2,711 | 0.0% | 0.08% | -26.2% |
Q2 2016 | $274,000 | +20.2% | 2,711 | +12.7% | 0.10% | +19.8% |
Q1 2016 | $228,000 | -11.3% | 2,406 | -13.1% | 0.09% | -13.1% |
Q4 2015 | $257,000 | +8.9% | 2,769 | 0.0% | 0.10% | +10.0% |
Q3 2015 | $236,000 | -8.5% | 2,769 | -8.3% | 0.09% | -3.2% |
Q2 2015 | $258,000 | +0.8% | 3,019 | 0.0% | 0.09% | +1.1% |
Q1 2015 | $256,000 | +12.8% | 3,019 | +13.9% | 0.09% | +9.5% |
Q4 2014 | $227,000 | +7.6% | 2,650 | -4.7% | 0.08% | +5.0% |
Q3 2014 | $211,000 | -11.7% | 2,780 | -8.6% | 0.08% | -16.7% |
Q2 2014 | $239,000 | -6.6% | 3,040 | -11.1% | 0.10% | -15.0% |
Q1 2014 | $256,000 | -3.0% | 3,420 | 0.0% | 0.11% | -3.4% |
Q4 2013 | $264,000 | +11.4% | 3,420 | 0.0% | 0.12% | +3.5% |
Q3 2013 | $237,000 | +9.7% | 3,420 | 0.0% | 0.11% | +1.8% |
Q2 2013 | $216,000 | – | 3,420 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |